Navigation Links
Promise of a New Lupus Treatment Is a Groundbreaking Achievement
Date:11/2/2009

BENLYSTA(TM) Successful in Second Pivotal Clinical Trial

WASHINGTON, Nov. 2 /PRNewswire-USNewswire/ -- Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).

Both trials demonstrate that treatment with BENLYSTA plus standard of care was superior to that of placebo (inactive agent) plus standard of care. BENLYSTA significantly reduced disease activity. If approved by the FDA, BENLYSTA would be the first drug ever developed and approved specifically for the treatment of lupus.

Sandra C. Raymond, President and Chief Executive Officer of the Lupus Foundation of America (LFA) issued the following statement.

"We are truly excited to receive this groundbreaking news! Individuals with lupus and their families have waited more than 50 years to hear that it is possible to develop therapies that control the disease. We believe that this is a significant first step in developing the full arsenal of therapies and personalized treatment lupus requires.

"Conducting clinical trials in lupus has been extremely difficult due to many factors including the heterogeneity of the disease, the selection of appropriate clinical trial endpoints, and the confounding role of required background medications given to clinical trial participants. Human Genome Sciences and GlaxoSmithKline have proven that these barriers, while formidable, can be overcome.

"For decades the entire lupus research community has worked hard to better understand the causes and conseq
'/>"/>

SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
2. New nanostructured thin film shows promise for efficient solar energy conversion
3. Phase 1 Studies Show Promise of QuatRxs Novel Compound, Sobetirome, for Lowering LDL Cholesterol Levels
4. New Robotic Imaging Technology Holds Promise of Improved Cancer Care
5. Nanoemulsion vaccines show increasing promise
6. NIST/NIH micromagnets show promise as colorful smart tags for magnetic resonance imaging
7. Nano-sized electronic circuit promises bright view of early universe
8. Telescope Embedded in Spectacle Lens Promises to Make Driving Easier for Visually Impaired
9. New carbon material shows promise of storing large quantities of renewable electrical energy
10. New research field promises radical advances in optical technologies
11. Cord Blood America Salutes President-Elect Obamas Promise to Lift Restrictions on Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...s of cell-phone users when they call 911, making i...he necessary equipment. , ,The system has been in ...ld-tested, according to The Reporter . , ,In one ...alled in and was found 50 feet from the location t...e reported that the state will reimburse the coun...
... just recently and we didn,t hire him. , ,It was a... test when he came to the interview: "Tell us what...d: "Though I don,t know too much just now, I am ex..., ,It,s simply too easy for any job seeker to rese...do so. Midwest technology types have at least a do...
.... The grand majesty of the IT industry is huddled ...h, we send the occasional skirmish over into the K...e think "the business" is, but our maps of the wor...miliar territories of technology. , ,Then there,s ...here be dragons or business execution or maybe the...
Other Biology Technology:Hone your pre-interview skills or you may lose that tech job 2Hone your pre-interview skills or you may lose that tech job 3Hone your pre-interview skills or you may lose that tech job 4Hone your pre-interview skills or you may lose that tech job 5Information technology past the end of the Earth 2Information technology past the end of the Earth 3
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2A window that washes itself? 2Fish with attitude: Some like it hot 2Vitamin D May Be Tied to Heart Disease Via Genes 62564 1Vitamin D May Be Tied to Heart Disease Via Genes 62564 2Northern California Cancer Centers Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Rese 62562 1Northern California Cancer Centers Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Rese 62562 2Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 62560 1Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 62560 2
...quirrels are immune to squirrelpox viral disease, ...f the species, scientists have discovered. , Sci...SL) have identified eight cases in which free-livi...squirrelpox virus by mounting an immune response. ...ournal Ecohealth . , Dr. Anthony Sainsbury, ZS...
...6, 2008) NARSAD, the world,s leading charity dedi...nual prizes tomorrow -- among the most coveted in ...ntists whose research in the areas of schizophren...orders and cognitive neuroscience have led to sign... of mental illness. , The prizes will be presen...
...essor of molecular biology at Rockefeller Universi...tical physics at New York University and at CERN i...er von Humboldt professorships ever to be awarded....ted the two scientists for this distinction, and b...ndation panel. This distinction, which comes with ...
Other Biology News:New hope for the red squirrel 2NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders 2NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders 3NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders 4NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders 5NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders 6NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders 7NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders 82 Alexander von Humboldt professorships go to LMU Munich 22 Alexander von Humboldt professorships go to LMU Munich 32 Alexander von Humboldt professorships go to LMU Munich 42 Alexander von Humboldt professorships go to LMU Munich 5
BD Falcon TufRol Cell Culture Flask, 25 cm2 from BD Biosciences - Discovery Labware
Mouse Anti-HLA, Class II Antigen-DR+DP Monoclonal Antibody, Unconjugated, Clone 236-14240 from Meridian Life Science, Inc.
BD Falcon Cell Culture Flask, 25 cm2 from BD Biosciences - Discovery Labware
...tyrene with frosted labeling surfaces, volume grad...ting. 100% integrity tested. Linkage: This CLS num...ch Cornings product number. If showing no availabi... number (C0177) or contact customer service for as...
Biology Products: